I have my ophthalmology practical exam tomorrow. For that I need, I have a station called as Ophthalmology Instruments, then Perimetry, and also HFA station. So I need a complete review on all the ophthalmic medications used, especially the anti-glaucoma drugs that are used in the treatment of glaucoma and also about the instruments, instruments like chalazionclamp, aireviseration scoop, then corneoscleral scissors, then etc., and two-way irrigation cannula, etc., and many more instruments, and also on systemic and community ophthalmology. Give me a complete and brief in everything, especially the medications I need, the indications, contraindications, the dose, what is the mechanism of action, and which class of drug does the drug belong to, etc.

Reading File
Good - I have the skill instructions. Now let me run parallel searches across all the topics needed for this ophthalmology exam review.
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
I found two ophthalmology textbooks. Let me now read from Kanski's and Wills Eye Manual for the drug and instrument content.
Finding Sources
Searching the Web

anti-glaucoma drugs complete review prostaglandins beta blockers carbonic anhydrase inhibitors alpha agonists mechanism dose indications

Now let me read the key sections from Kanski's Ophthalmology on medical treatment of glaucoma, and the HFA/perimetry content.
Reading File
Searching the Web

ophthalmic surgical instruments chalazion clamp evisceration scoop corneoscleral scissors two-way irrigation cannula identification uses

Excellent! Now let me read more of the Kanski glaucoma drug section and also get systemic ophthalmology content.
Reading File
Searching the Web

systemic ophthalmology ocular manifestations diabetes hypertension thyroid rheumatoid arthritis review ophthalmology exam

Reading Web Page

https://en.wikipedia.org/wiki/List_of_instruments_used_in_op…

Now let me read more of the Kanski book - the beta-blockers, CAIs, alpha agonists sections, and get community ophthalmology content.
Reading File
Searching the Web

community ophthalmology VISION 2020 blindness causes prevention national programs trachoma vitamin A deficiency

I now have comprehensive information to write the complete review. Let me compile everything into a well-structured, exam-ready document.Here is your complete, exam-ready ophthalmology review. Good luck tomorrow!

COMPLETE OPHTHALMOLOGY PRACTICAL EXAM REVIEW

Stations: Instruments | Perimetry | HFA | Medications | Systemic & Community Ophthalmology

PART 1: ANTI-GLAUCOMA DRUGS (COMPLETE PHARMACOLOGY)

The goal of all anti-glaucoma drugs is to lower intraocular pressure (IOP) - either by reducing aqueous production or increasing aqueous outflow.

CLASS 1: PROSTAGLANDIN ANALOGUES (PGAs) - FIRST LINE

FeatureDetails
ClassProstaglandin FP-receptor agonists
MOAIncrease uveoscleral outflow (main) + some trabecular outflow
IOP reduction27-35% from baseline (most potent class)
DosingOnce daily at BEDTIME

Agents & Doses:

DrugConcentrationNotes
Latanoprost (Xalatan)0.005% dropsFirst-line; fewest ocular side effects
Travoprost (Travatan Z)0.004% dropsFewer non-responders than latanoprost
Bimatoprost (Lumigan)0.03% / 0.01% dropsSlightly greater IOP reduction; more hyperaemia
Tafluprost0.0015% dropsPreservative-free; less ocular surface disruption
Latanoprostene bunod (Vyzulta)0.024%Also releases nitric oxide - dual mechanism

Indications:

  • Primary open-angle glaucoma (POAG) - first-line
  • Ocular hypertension

Contraindications:

  • Active uveitis / intraocular inflammation
  • Herpetic eye disease
  • Aphakic patients / history of cystoid macular edema (CME)
  • Recent intraocular surgery
  • Pregnancy (Pregnancy Category C)
  • Do NOT use two PGAs simultaneously (paradoxically raises IOP)

Side Effects:

Ocular (classic exam questions):
  • Conjunctival hyperaemia (most common)
  • Iris hyperpigmentation (irreversible) - highest in green-brown irides
  • Eyelash lengthening, thickening, hyperpigmentation (hypertrichosis)
  • Periocular skin hyperpigmentation (reversible)
  • Periocular fat atrophy/sunken appearance (prostaglandin-associated periorbitopathy)
  • Anterior uveitis (rare)
  • Cystoid macular edema post-cataract surgery
Systemic: Minimal - major advantage over beta-blockers

CLASS 2: BETA-ADRENERGIC BLOCKERS

FeatureDetails
MOABlock beta-2 receptors on ciliary body epithelium → reduce aqueous production
IOP reduction20-30%
DosingOnce or twice daily

Agents & Doses:

DrugTypeConcentrationDose
Timolol (Timoptic)Non-selective (β1+β2)0.25%, 0.5%BD or OD (gel-forming)
Levobunolol (Betagan)Non-selective0.25%, 0.5%OD or BD
Betaxolol (Betoptic)β1-selective0.25%, 0.5%BD
CarteololNon-selective with ISA1%, 2%BD

Indications:

  • POAG, ocular hypertension
  • Often used as second-line or in combination

Contraindications (CRITICAL for exam):

  • Bronchial asthma / COPD (bronchospasm risk - non-selective > selective)
  • Sinus bradycardia / heart block / cardiac failure (systemic absorption causes bradycardia)
  • Betaxolol is preferred in mild/moderate asthma (β1-selective, relatively safer)
  • Pregnancy (Category C)
  • Caution in diabetes (masks hypoglycemia symptoms)
  • Depression (CNS side effects)

Side Effects:

Ocular: Dry eye, reduced corneal sensitivity, superficial punctate keratopathy Systemic: Bradycardia, hypotension, bronchospasm, fatigue, impotence, depression
Tip: Systemic absorption via nasolacrimal drainage causes systemic effects. Punctal occlusion or eyelid closure for 3 minutes after instillation reduces systemic absorption by ~50%.

CLASS 3: ALPHA-2 ADRENERGIC AGONISTS

FeatureDetails
MOAStimulate α2 receptors → reduce aqueous production + increase uveoscleral outflow
IOP reduction20-25%
Dosing2-3 times daily

Agents & Doses:

DrugConcentrationNotes
Brimonidine (Alphagan P)0.1%, 0.15%, 0.2%Selective α2 agonist; also neuroprotective
Apraclonidine (Iopidine)0.5%, 1%Less selective; mainly for short-term use or peri-laser

Indications:

  • Second/third-line for glaucoma
  • Apraclonidine: prevention of post-laser IOP spike (used peri-ALT/YAG)
  • Adjunctive therapy

Contraindications:

  • Children < 2 years (CNS depression risk - can cause apnea, bradycardia, hypotension)
  • Brimonidine contraindicated in children < ~20 kg / infants (CNS penetration)
  • MAO inhibitor users (hypertensive crisis)
  • Severe cardiovascular disease
  • Pregnancy

Side Effects:

Ocular: Allergic conjunctivitis (up to 25% with brimonidine), follicular conjunctivitis, miosis, uveitis (rare) Systemic: Dry mouth, dry nose, drowsiness, fatigue, headache Brimonidine specifically: Bradycardia, hypotension, hypothermia, hypotonia, apnea in neonates/infants

CLASS 4: CARBONIC ANHYDRASE INHIBITORS (CAIs)

A. TOPICAL CAIs

FeatureDetails
MOAInhibit carbonic anhydrase II in ciliary body epithelium → reduce aqueous production
IOP reduction15-20%
Dosing2-3 times daily
DrugConcentrationDose
Dorzolamide (Trusopt)2%TDS (3x/day)
Brinzolamide (Azopt)1%BD-TDS
Side effects (topical): Stinging/burning (especially dorzolamide), bitter taste, superficial punctate keratopathy, blepharoconjunctivitis

B. SYSTEMIC CAIs

DrugFormDoseNotes
Acetazolamide (Diamox)Tablet 250 mg / IV 500 mg250-1000 mg/day dividedMost commonly used; IV used in acute angle-closure
DichlorphenamideTablet 50 mg50-100 mg BD-TDS
MethazolamideTablet 50 mg50-100 mg BD-TDSLonger duration; less widely available

Contraindications:

  • Sulfonamide allergy (relative contraindication - cross-reactivity)
  • Hypokalemia
  • Renal failure / renal stones
  • Pregnancy (teratogenicity risk - greatest systemic risk among all glaucoma drugs)
  • Sickle cell disease (acidosis risk)
  • Hepatic failure

Side Effects (Systemic CAIs - HIGH-YIELD):

  • Paraesthesia ("pins and needles" in extremities) - most common
  • Hypokalemia (give potassium supplements)
  • Malaise, lowered mood, fatigue
  • GI symptoms (nausea, vomiting, metallic taste)
  • Renal stones (nephrolithiasis)
  • Stevens-Johnson syndrome (very rare)
  • Aplastic anemia (idiosyncratic, rare, 50% mortality)
  • Bone marrow suppression (dose-related)

CLASS 5: MIOTICS (CHOLINERGIC AGENTS)

FeatureDetails
MOAStimulate muscarinic receptors → ciliary muscle contraction → opens trabecular meshwork → increases aqueous outflow
IOP reduction20-30%
Dosing4 times daily (short acting)
DrugConcentrationNotes
Pilocarpine0.5%, 1%, 2%, 4%Most used miotic; gel 4% for nocturnal use
Carbachol0.75-3%More potent; penetrates poorly
Echothiophate0.03-0.25%Irreversible anticholinesterase; rarely used now

Indications:

  • Acute angle-closure glaucoma (breaks attack by pulling iris away from angle)
  • POAG (now rarely used; fourth-line)
  • Pilocarpine also used: before/after goniotomy, iridotomy

Contraindications:

  • Active uveitis (worsen inflammation, cause posterior synechiae)
  • Neovascular glaucoma
  • After penetrating keratoplasty
  • Aphakia (risk of retinal detachment)
  • Asthma (systemic absorption)

Side Effects:

  • Miosis → reduced vision in dim light
  • Brow ache / headache (ciliary spasm) - common initially
  • Myopia (accommodation spasm)
  • Cataract with long-term use (posterior subcapsular)
  • Retinal detachment (especially in aphakia/myopia)
  • Systemic: SLUDGE syndrome (Salivation, Lacrimation, Urination, Defecation, GI cramps, Emesis) with toxicity

CLASS 6: OSMOTIC AGENTS (for acute IOP reduction)

FeatureDetails
MOACreate osmotic gradient → draw water from vitreous into blood → rapid IOP reduction
UseShort-term acute management (acute angle-closure glaucoma, pre-surgery)
DrugRouteDoseOnsetNotes
MannitolIV1 g/kg (20% solution, 5 ml/kg) over 30-60 min30 minMost commonly used
Glycerol (Glycerin)Oral1 g/kg (50% solution, 2 ml/kg)1 hourSweet taste; metabolized to glucose - caution in diabetics; give with lemon juice
IsosorbideOralSame as glycerol1-2 hoursMetabolically inert; safer in diabetics

Contraindications:

  • Cardiac failure / severe renal disease (fluid overload risk)
  • Diabetics (glycerol only - use isosorbide instead)
  • Urinary retention in elderly men (caution)
  • Inflammatory glaucoma (blood-aqueous barrier disrupted - limited effect)

CLASS 7: RHO-KINASE INHIBITORS (ROCK inhibitors) - NEWER CLASS

FeatureDetails
DrugNetarsudil (Rhopressa)
MOAInhibit ROCK → relax trabecular meshwork cells → increase conventional (trabecular) outflow
Dose0.02% once daily
AlsoReduces episcleral venous pressure + reduces aqueous production
Side effectsConjunctival hyperaemia, conjunctival hemorrhage, corneal verticillata (deposits)
CombinationRocklatan = netarsudil + latanoprost

COMBINATION DRUGS (HIGH-YIELD):

Combination ProductComponents
CosoptDorzolamide 2% + Timolol 0.5%
CombiganBrimonidine 0.2% + Timolol 0.5%
SimbrinzaBrinzolamide 1% + Brimonidine 0.2%
XalacomLatanoprost + Timolol
DuoTravTravoprost + Timolol
GanfortBimatoprost + Timolol
RocklatanNetarsudil + Latanoprost

DRUG CLASS SUMMARY TABLE (QUICK REVIEW):

ClassExampleMOAIOP ↓Dose
PGALatanoprost↑ uveoscleral outflow27-35%OD at night
Beta blockerTimolol↓ aqueous production20-30%OD-BD
Alpha-2 agonistBrimonidine↓ production + ↑ outflow20-25%BD-TDS
CAI (topical)Dorzolamide↓ aqueous production15-20%BD-TDS
CAI (systemic)Acetazolamide↓ aqueous production30-40%QDS
MioticPilocarpine↑ trabecular outflow20-30%QDS
OsmoticMannitolOsmotic dehydration35-45%Single IV
ROCK inhibitorNetarsudil↑ trabecular outflow~20%OD

PART 2: OPHTHALMIC INSTRUMENTS


EYELID INSTRUMENTS

1. Chalazion Clamp (Chalazion Forceps)

  • Appearance: Self-retaining instrument with one discoid ring plate on one arm and a solid oval plate on the other
  • Size: Multiple sizes available (Lambert: 10 mm/15 mm round; Francis: 16x13 mm oval)
  • Use: Applied to evert the eyelid and provide hemostasis during excision of a chalazion (Meibomian cyst)
  • Mechanism: The ring end faces outward (toward conjunctival side); scalpel incision made through the ring; the plates clamp the eyelid to prevent bleeding
  • Key point: Self-retaining; leaves hands free for surgery

2. Chalazion Scoop / Curette

  • Appearance: Small sharp spoon-shaped instrument
  • Use: To scrape out granulation tissue from the chalazion cavity after incision
  • Sizes: A, B, C, D, E, F (varying cup sizes - 2.2 mm to 5.7 mm)

3. Meibomian Cyst Curette

  • Double-ended with two cupped ends
  • Used to express and clean out Meibomian cyst contents

4. Entropion Clamp

  • Similar to chalazion clamp but larger
  • Right and left varieties exist
  • Self-retaining with big discoid ends
  • Used in entropion surgery

SCISSORS

5. Corneoscleral Scissors

  • Appearance: Spring scissors with curved/straight blades; one blade fits into the anterior chamber
  • Use: To extend corneoscleral incision during cataract extraction, penetrating keratoplasty, or evisceration
  • Types: Right-cutting and left-cutting varieties (complementary pair)
  • Key: The curved blade is inserted into the incision and the scissor cuts along the limbus

6. Conjunctival/Tenotomy Scissors (Westcott/Stevens)

  • Fine spring scissors
  • Used for conjunctival dissection, undermining, and suture cutting
  • Stevens: straight or curved, rounded tips
  • Westcott: curved, spring-action, for delicate work

7. Vannas Scissors

  • Very fine, small scissors
  • Capsulotomy, iris work, fine intraocular cutting

8. Iris Scissors

  • Intraocular scissors for iris procedures

CANNULAE

9. Two-Way (Bi-way) Irrigation-Aspiration Cannula

  • Appearance: Two cannulae fitted side by side - one larger (irrigation) and one smaller (aspiration)
  • Use: During cataract surgery (ECCE) - one channel infuses BSS (balanced salt solution) to maintain anterior chamber depth; the other aspirates cortical material
  • Function: Removes residual lens cortex after nucleus delivery; prevents chamber collapse
  • Connected to: I/A machine or two separate syringes

10. Lacrimal Cannula

  • Small, curved cannula the size of a syringe needle
  • Use:
    • Syringing of nasolacrimal duct (test patency)
    • DCR (dacryocystorhinostomy) surgery
    • Dacryocystography (contrast injection)
    • Drug delivery into nasolacrimal passages
  • Types: Straight, angled 45°, angled 90°

11. Irrigating Vectis

  • Hollow instrument with a loop at the end
  • Use: Introduce fluid into anterior chamber to raise pressure and aid nucleus delivery in cataract surgery; also used to deliver nucleus into anterior chamber

EVISCERATION INSTRUMENTS

12. Evisceration Spoon (Evisceration Scoop / Mules Scoop)

  • Appearance: Spoon-shaped scoop with smooth, blunt edges
  • Use: Used in evisceration surgery - to scoop out the intraocular contents (uveal tract, retina, vitreous, lens) after cornea is removed, leaving the scleral shell intact
  • Key distinction: Evisceration = removal of intraocular contents; Enucleation = removal of entire eyeball
  • After scooping: Implant placed into the scleral shell
  • Also used: To place orbital implant into the scleral shell

FORCEPS

13. Tissue/Fixation Forceps (St Martin's, Lim's)

  • Used to fix/hold the globe during surgery

14. Colibri Forceps / Corneal Forceps

  • Fine toothed (0.12 mm) or non-toothed
  • For holding corneal tissue during suturing

15. Capsule Forceps (Utrata Forceps)

  • Fine curved forceps for continuous curvilinear capsulorhexis (CCC) in phacoemulsification

16. MacPherson's Forceps

  • Fine, sharp-tipped, untoothed, angulated
  • For holding IOL, 10-0 sutures, fine intraocular work

17. Epilation Forceps (Cilia Forceps)

  • Stout, flat-ended, blunt forceps with thickened ends
  • Use: Remove misdirected eyelashes (trichiasis)

18. Bishop-Harmon Forceps

  • General ophthalmic tissue forceps; serrated + 1x2 teeth options

SPECULA

19. Barraquer Wire Speculum

  • Wire loop speculum to hold eyelids apart during surgery
  • Minimally obstructs surgical field
  • Self-retaining

20. Universal Eye Speculum (Lancaster speculum)

  • Blade-type, adjustable, more rigid
  • Used for exam or surgery

NEEDLES & KNIVES

21. Cystotome

  • 26-gauge needle bent twice at right angles
  • Use: To incise the anterior lens capsule (capsulotomy) in ECCE; also used for can-opener capsulotomy

22. Keratome (Angular Keratotome)

  • Angled knife for creating clear corneal incisions

23. Von Graefe's Cataract Knife

  • Classic knife for ECCE incision; now largely replaced by phaco needles

PROBES & DILATORS

24. Bowman's Lacrimal Probe

  • Flexible silver probe in graduated sizes
  • Use: Probing (syringing) blocked nasolacrimal duct; especially in infants with congenital dacryostenosis

25. Nettleship's Punctum Dilator

  • Conical metal dilator
  • Use: Dilate the lacrimal punctum before syringing or lacrimal surgery

MISCELLANEOUS HIGH-YIELD INSTRUMENTS

26. Lens Loop / Vectis (Wire Vectis)

  • Loop of wire on a handle
  • Use: To extract cataract nucleus during ECCE; slides under the nucleus to deliver it

27. Iris Repositor / Iris Spatula

  • Flat, blunt spatula
  • Use: To reposition the iris, separate synechiae, protect the iris during surgery

28. Rougine

  • Curved, flat, blunt dissector
  • Use: Blunt dissection of lacrimal sac during DCR; elevation of periosteum

29. Lang's Lacrimal Dissector with Scoop

  • Double-purpose instrument
  • Use: Blunt dissection and cleaning during DCR

30. Foreign Body Spud / Needle

  • Use: Remove superficial corneal foreign bodies; the spud end for metal particles

31. Callipers

  • Measuring instrument for precise distances
  • Use: Measuring surgical incision size, IOL positioning, extraocular muscle surgery

32. Retinoscope

  • Streak or spot illumination instrument
  • Use: Objective refraction to determine refractive error

33. Direct Ophthalmoscope

  • Use: Examination of fundus; gives ~15x magnification; monocular image; field of view ~2 disc diameters
  • Important: No stereopsis

34. Indirect Ophthalmoscope (Binocular Indirect Ophthalmoscope - BIO)

  • Head-mounted light source + condensing lens (20D, 28D, 30D)
  • Inverted, real image
  • Larger field of view (~8 disc diameters with 20D lens)
  • Better for peripheral retina, detachments, neonatal exams
  • Allows scleral indentation

35. Slit Lamp (Biomicroscope)

  • Used with various lenses for anterior and posterior segment examination

GLAUCOMA-SPECIFIC INSTRUMENTS

36. Goldmann Applanation Tonometer

  • Gold standard for IOP measurement
  • Uses fluorescein + cobalt blue light
  • Measures force needed to flatten (applanate) 3.14 mm area of cornea
  • Imbert-Fick law principle

37. Gonioscope (Goldmann, Zeiss, Volk)

  • Used with slit lamp to visualize the iridocorneal angle
  • Direct gonioscopy (Koeppe) vs indirect (Goldmann 3-mirror)
  • Critical for classifying open vs. closed angle glaucoma

38. Pachymeter

  • Ultrasonic or optical device
  • Measures central corneal thickness (CCT)
  • Important in glaucoma risk assessment and tonometry correction

PART 3: PERIMETRY AND HFA (HUMPHREY FIELD ANALYZER)


VISUAL FIELD EXAMINATION - OVERVIEW

Visual field testing (perimetry) assesses the full extent of a patient's field of vision, including peripheral vision.
Types of perimetry:
  1. Confrontation visual fields (bedside, clinical screening)
  2. Kinetic perimetry (Goldmann)
  3. Static automated perimetry (HFA, Octopus) - most used clinically
  4. Frequency-doubling technology (FDT) perimetry

GOLDMANN KINETIC PERIMETRY

  • Principle: Uses moving targets of varying size and intensity to map isopters
  • Bowl: Hemispherical, white, background illuminance 1000 asb (apostilbs)
  • Targets: Circular stimuli varying in size (I-V) and intensity (1-4)
    • Size: I (smallest, 0.25 mm²) to V (largest, 64 mm²)
    • Intensity/Filter: 1 (dimmest) to 4 (brightest)
  • Isopter: Line connecting points where target becomes visible as it moves from non-seeing to seeing area
  • Named stimuli: Written as e.g., V4e (Roman numeral = size, number = intensity, lowercase letter = filter)
  • Advantages: Full field assessment including far periphery; useful in neurological conditions; patient interaction helps reliability
  • Disadvantages: Requires skilled perimetrist; time-consuming; not standardized easily

Classic patterns:

  • Physiological blind spot: Temporal to fixation (~15° temporal); corresponds to optic disc
  • Central scotoma: Optic nerve/macula pathology
  • Arcuate scotoma: Glaucoma
  • Bitemporal hemianopia: Chiasmal lesion
  • Homonymous hemianopia: Post-chiasmal lesion

STANDARD AUTOMATED PERIMETRY (SAP) - HFA

Humphrey Field Analyzer (HFA) - Carl Zeiss Meditec

Principle: Static perimetry - tests fixed locations with stimuli of varying intensity to determine threshold sensitivity
Setup:
  • Patient seated at chin rest in center of testing bowl
  • Near refractive correction placed in the instrument
  • Contralateral eye occluded
  • Patient presses button when they see the stimulus
  • Background illuminance: 31.5 asb (standard)
  • Stimulus size: Goldmann III (most common), 0.43° diameter
  • Stimulus duration: 200 milliseconds

Testing Programs:

ProgramDescriptionUse
24-2Tests 54 points within central 24°Glaucoma standard
30-2Tests 76 points within central 30°Glaucoma, neurological
10-2Tests 68 points within central 10°Advanced glaucoma, macula
MaculaCentral 5° in detailMacular disease
Full-field 120Peripheral testingNeuro, retinitis pigmentosa

Threshold Algorithms:

AlgorithmDescription
Full ThresholdFull staircase method; most accurate; slowest
SITA StandardSwedish Interactive Threshold Algorithm; 50% faster than full threshold; standard for glaucoma
SITA Fast~50% faster than SITA Standard; less accurate; quick screening
SITA FasterFastest; single reversal; used when time is critical

HFA Printout - Key Parameters (MUST KNOW):

1. Reliability Indices (top right of printout):
IndexNormalSignificance
Fixation Losses (FL)< 20%Checks if patient looks away during test
False Positive Rate (FP)< 15%Trigger-happy patient; "clover" appearance
False Negative Rate (FN)< 33%Inattentive patient; may indicate advanced disease
2. Threshold Values Map: Numbers showing sensitivity in dB at each location; higher = better
3. Total Deviation Map:
  • Compares each point to age-matched normals
  • Shows total sensitivity loss
4. Pattern Deviation Map:
  • Corrects for generalized depression (e.g., cataract)
  • Shows focal defects; more specific for glaucoma
  • More reliable for detecting glaucomatous damage
5. Global Indices:
IndexDescriptionGlaucoma
MD (Mean Deviation)Average deviation from normal; overall sensitivityNegative (loss); > -6 dB = early; -6 to -12 = moderate; > -12 = advanced
PSD (Pattern Standard Deviation)Measures focal irregularity; variability between pointsElevated in glaucoma (focal loss)
GHT (Glaucoma Hemifield Test)Compares superior vs inferior hemifields; looks for asymmetry"Outside normal limits" in glaucoma
VFI (Visual Field Index)Overall field preservation %; used for progressionNormal = 100%; deterioration tracked over time

Classic Glaucomatous Visual Field Defects:

  1. Nasal step - abrupt step at horizontal meridian in nasal field
  2. Paracentral scotoma - near fixation
  3. Arcuate (Bjerrum) scotoma - follows nerve fiber layer from blind spot to nasal meridian
  4. Double arcuate / ring scotoma - superior + inferior arcuates join
  5. Advanced glaucoma: Only central island + temporal island remain
  6. End-stage: Total field loss (tunnel vision)

Artifact Recognition:

  • Rim artifact: Upper field depression from spectacle frame
  • Lens artifact: Central ring of depression
  • Ptosis: Superior field depression
  • Cataract/media opacity: Generalized depression (Total Deviation affected, Pattern Deviation often normal)

FREQUENCY-DOUBLING TECHNOLOGY (FDT) PERIMETRY

  • Tests magnocellular (M-cell) pathway
  • Uses low spatial frequency, high temporal frequency grating
  • Detects early glaucomatous loss
  • Quick and portable; good screening tool

PART 4: OPHTHALMIC MEDICATIONS (BROADER REVIEW)


TOPICAL ANTIBIOTICS

DrugClassCoverageUse
Chloramphenicol 0.5% dropsBroad-spectrumGram +/-Bacterial conjunctivitis (1st line in many countries)
Ciprofloxacin 0.3%FluoroquinoloneBroad + PseudomonasBacterial keratitis, conjunctivitis
Ofloxacin 0.3%FluoroquinoloneBroadSimilar to ciprofloxacin
Moxifloxacin 0.5%Fluoroquinolone (4th gen)BroadestSevere keratitis, endophthalmitis prophylaxis
Tobramycin 0.3%AminoglycosideGram - (Pseudomonas)Bacterial conjunctivitis, keratitis
Gentamicin 0.3%AminoglycosideGram -Bacterial infections
Fusidic acid 1% gelFusidaneGram + (Staph)Staphylococcal blepharoconjunctivitis
Erythromycin 0.5% ointMacrolideGram +Neonatal ophthalmia prophylaxis, chlamydia
Tetracycline 1% ointTetracyclineBroadTrachoma, rosacea
Azithromycin 1% dropsMacrolideBroadChlamydial conjunctivitis, trachoma

TOPICAL ANTIVIRALS

DrugMOAUse
Acyclovir 3% ointThymidine kinase → chain terminatorHSV keratitis (dendritic ulcer)
Ganciclovir 0.15% gelSimilar to acyclovirHSV keratitis
Trifluridine 1% dropsInhibits thymidylate synthetaseHSV keratitis

TOPICAL ANTIFUNGALS

DrugUse
Natamycin 5%Fungal keratitis (filamentous - Aspergillus, Fusarium) - FIRST LINE
Voriconazole 1%Fungal keratitis (broader)
Fluconazole dropsCandida keratitis
Amphotericin B 0.15%Fungal keratitis; also intravitreal for fungal endophthalmitis

TOPICAL CORTICOSTEROIDS

DrugPotencyNotes
Prednisolone 1%HighSevere anterior segment inflammation; risk of cataract/glaucoma
Dexamethasone 0.1%HighPostoperative inflammation
Fluorometholone (FML) 0.1%LowLess IOP rise; allergic conjunctivitis, mild inflammation
Loteprednol 0.5%Soft steroidMinimal IOP effect; allergic conditions
Rimexolone 1%MediumAnterior uveitis
Steroid side effects (local): IOP elevation (steroid-induced glaucoma), posterior subcapsular cataract, worsening of HSV/fungal infections, delayed wound healing
Rule: NEVER use steroids with a dendritic (HSV) corneal ulcer!

TOPICAL NSAIDs

DrugUse
Diclofenac 0.1%Post-op inflammation, pain; CME prevention
Ketorolac 0.5%CME prevention post-cataract; seasonal allergic conjunctivitis
Bromfenac 0.09%Post-op inflammation (OD dosing)
Nepafenac 0.1%Prodrug; post-op, CME

MYDRIATICS AND CYCLOPLEGICS

DrugClassMOADilationCycloplegiaDuration
Tropicamide 0.5%, 1%AntimuscarinicBlocks M3 receptorsYesMinimal4-6 hrs
Cyclopentolate 0.5%, 1%, 2%AntimuscarinicSameYesGood24 hrs
Atropine 1%AntimuscarinicSameMaxMax10-14 days
Homatropine 2%, 5%AntimuscarinicSameYesModerate1-3 days
Phenylephrine 2.5%, 10%Alpha agonistDilates pupil (no cycloplegia)YesNo3-5 hrs
Tropicamide - fastest onset/offset; used for routine fundal exam Cyclopentolate - preferred for refraction in children Atropine - penalization in amblyopia; uveitis to prevent posterior synechiae; maximum cycloplegia needed
Contraindications to mydriatics: Narrow-angle / angle-closure glaucoma

MIOTICS (DIAGNOSTIC)

DrugUse
Pilocarpine 0.1%Pharmacological miosis in Adie's pupil (supersensitivity - dilute drops cause constriction)
Pilocarpine 1%Breaks acute angle-closure glaucoma attack
Cocaine 4%Horner's syndrome diagnosis (normal pupil dilates; Horner's pupil fails to dilate)
Apraclonidine 0.5%Horner's test (causes dilation in Horner's due to denervation supersensitivity)
Hydroxyamphetamine 1%Distinguishes pre- vs post-ganglionic Horner's

LUBRICANTS / ARTIFICIAL TEARS

  • Hypromellose (hydroxypropyl methylcellulose) - standard tear substitute
  • Carbomer gel (polyacrylic acid) - longer lasting
  • Sodium hyaluronate drops - viscous, good retention
  • Carmellose (CMC) - common OTC drops
  • Lacrilube / Vit-A-Pos ointment - severe dry eye, nocturnal use
Use: Dry eye disease, exposure keratopathy, post-surgical

INTRAVITREAL INJECTIONS (ANTI-VEGF)

DrugTargetHalf-lifeIndications
Bevacizumab (Avastin)All VEGF-A isoforms~20 daysWet AMD, DME, CRVO (off-label)
Ranibizumab (Lucentis)VEGF-A fragment~9 daysWet AMD, DME, CRVO, CNV
Aflibercept (Eylea)VEGF-A, VEGF-B, PlGF~20 daysWet AMD, DME, CRVO
Faricimab (Vabysmo)VEGF-A + Ang-2~7.5 daysWet AMD, DME (bispecific antibody)
Brolucizumab (Beovu)VEGF-A (all isoforms)Longer intervalWet AMD

PART 5: SYSTEMIC OPHTHALMOLOGY


DIABETES MELLITUS - Ocular Manifestations

1. Diabetic Retinopathy (DR)

Classification:
Non-Proliferative DR (NPDR):
  • Mild NPDR: Microaneurysms only
  • Moderate NPDR: Microaneurysms + dot-blot hemorrhages + hard exudates + cotton wool spots
  • Severe NPDR (4-2-1 Rule):
    • 4 quadrants of retinal hemorrhages, OR
    • 2 quadrants of venous beading, OR
    • 1 quadrant of intraretinal microvascular abnormalities (IRMA)
Proliferative DR (PDR):
  • New vessels on disc (NVD) or elsewhere (NVE)
  • Vitreous hemorrhage
  • Tractional retinal detachment
  • Neovascular glaucoma (rubeosis iridis)
Diabetic Macular Edema (DME): Thickening within 500 μm of fovea - main cause of vision loss in DR

2. Other Ocular Manifestations of DM:

  • Cataract: Earlier onset "snowflake" (sorbitol accumulation); more common posterior subcapsular
  • Cranial nerve palsies: III (with pupil sparing - diabetic mononeuropathy), IV, VI
  • Refractive changes: Hyperglycemia → myopia (lens swelling); hyperopia when glucose drops
  • Rubeosis iridis (NVI): Neovascularization of iris → neovascular glaucoma
  • Increased susceptibility to infections: Orbital cellulitis, mucormycosis

Treatment of DR:

  • Control of systemic risk factors (HbA1c, BP, lipids)
  • Laser photocoagulation: Pan-retinal photocoagulation (PRP) for high-risk PDR/severe NPDR
  • Anti-VEGF intravitreal (ranibizumab, bevacizumab, aflibercept): DME, proliferative DR
  • Vitrectomy: Vitreous hemorrhage not clearing, tractional detachment

HYPERTENSION - Ocular Manifestations

Hypertensive Retinopathy (Keith-Wagener-Barker Classification):

GradeFeatures
Grade IArteriolar narrowing (arteriovenous ratio < 2:3); subtle AV nicking
Grade IIDefinite AV nicking (Salus sign); copper/silver wiring of arterioles
Grade IIICotton wool spots, flame hemorrhages, hard exudates (macular star)
Grade IVGrade III + papilledema (disc edema) - malignant hypertension
AV crossing changes: Salus sign (deviation), Gunn sign (tapering), Bonnet sign (banking)
Other vascular ocular effects of hypertension:
  • Central/branch retinal artery occlusion (CRAO/BRAO)
  • Central/branch retinal vein occlusion (CRVO/BRVO)
  • Accelerated/malignant hypertension → choroidal ischemia (Elschnig's spots)

THYROID EYE DISEASE (Graves' Ophthalmopathy / TED)

Associations: Graves' disease (most common), Hashimoto's, even euthyroid state
Pathophysiology: Autoimmune - TSH receptor antibodies activate orbital fibroblasts → glycosaminoglycan deposition + T-cell infiltration → orbital fat expansion + extraocular muscle enlargement

Clinical Features (NOSPECS / CAS classification):

FeatureDescription
Proptosis (exophthalmos)Axial; bilateral (may be asymmetric)
Lid retractionUpper lid retraction (Dalrymple's sign) - most common sign
Lid lagOn downgaze (von Graefe's sign)
Periorbital edema/chemosis
Restrictive myopathyEOM fibrosis; IR most common (hypotropia, diplopia on upgaze)
Corneal exposureFrom proptosis/lagophthalmos → exposure keratopathy
Compressive optic neuropathyVisual loss - emergency! (apical crowding)
Signs:
  • Dalrymple's sign - lid retraction
  • Von Graefe's sign - lid lag on downgaze
  • Stellwag's sign - infrequent blinking
  • Joffroy's sign - no wrinkling on upgaze
  • Moebius sign - convergence weakness
Treatment: Orbital decompression, steroids (IV pulse), orbital radiotherapy, selenium, teprotumumab (IGF-1R inhibitor - newer)

RHEUMATOID ARTHRITIS

ManifestationFeatures
Dry eye / KCSMost common (up to 30%); lacrimal & Meibomian gland dysfunction
EpiscleritisMild; sectoral redness; self-limiting
ScleritisSevere pain; can perforate (scleromalacia perforans)
Peripheral corneal ulcerationPeripheral ulcerative keratitis (PUK) - sight-threatening
UveitisLess common than in JIA

SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

  • Dry eye (similar to RA)
  • Retinal vasculitis - cotton wool spots from ischemia (lupus retinopathy)
  • Retinal vein/artery occlusions
  • Scleritis, episcleritis
  • Hydroxychloroquine toxicity (bull's-eye maculopathy) - screening needed

SARCOIDOSIS

  • Anterior uveitis (most common ocular manifestation)
  • Posterior uveitis: "candle-wax drippings" (periphlebitis)
  • Conjunctival nodules (biopsy diagnostic)
  • Lacrimal gland involvement (dry eye)
  • Optic nerve granuloma
  • Band keratopathy (chronic hypercalcemia)

HIV/AIDS

  • CMV retinitis (most common serious ocular manifestation in AIDS)
    • CD4 < 50 cells/μL
    • "Pizza-pie / tomato-ketchup" appearance (hemorrhagic necrosis)
    • Treatment: Ganciclovir IV/oral, valganciclovir, foscarnet, cidofovir
  • HIV retinopathy: Cotton wool spots (most common)
  • Toxoplasma chorioretinitis ("headlight in fog")
  • Pneumocystis choroidopathy
  • Herpes zoster ophthalmicus (HZO)
  • Molluscum contagiosum eyelids

TUBERCULOSIS

  • Choroiditis / subretinal granuloma (tuberculoma)
  • Anterior uveitis (granulomatous)
  • Optic neuritis
  • Interstitial keratitis (Cogan's syndrome - actually syphilis but TB can cause IK too)
  • Scleritis, episcleritis

MULTIPLE SCLEROSIS

  • Optic neuritis - most common presentation; unilateral vision loss, RAPD, pain on eye movement
  • Internuclear ophthalmoplegia (INO) - MLF lesion; adduction failure + contralateral nystagmus
  • Uveitis (rare)
  • Nystagmus

DRUG-INDUCED OCULAR TOXICITY (HIGH-YIELD)

DrugOcular Effect
Chloroquine/HydroxychloroquineBull's-eye maculopathy (premacular pigment changes)
EthambutolToxic optic neuropathy (dyschromatopsia, visual loss)
AmiodaroneCornea verticillata (whorl keratopathy); optic neuropathy
TamoxifenCrystalline maculopathy; optic neuritis
SteroidsPosterior subcapsular cataract; steroid-induced glaucoma
Sildenafil (Viagra)Blue tinge, altered color vision (inhibits PDE6 in retina)
VigabatrinPeripheral visual field constriction (irreversible)
ThioridazinePigmentary retinopathy (RP-like)
RifampicinRed-orange discoloration of tears (contact lens staining)
TetracyclineRaised intracranial pressure (pseudotumor cerebri)
DigitalisYellow vision (xanthopsia), halos

PART 6: COMMUNITY OPHTHALMOLOGY


DEFINITIONS (KEY TERMS)

TermWHO Definition
Normal visionBest-corrected visual acuity (BCVA) ≥ 6/18 (0.3)
Visual impairment (low vision)BCVA < 6/18 to ≥ 3/60 in better eye
BlindnessBCVA < 3/60 (or visual field < 10°) in better eye
Severe visual impairmentBCVA < 6/60 to ≥ 3/60
Economic blindness (India)BCVA < 6/60 in better eye
Social blindnessBCVA < 3/60

GLOBAL BURDEN OF BLINDNESS

  • ~43 million people blind worldwide (2020)
  • ~295 million with moderate/severe visual impairment
  • >80% of blindness is avoidable (preventable or treatable)
  • >90% of blind people live in low/middle-income countries (LMICs)

Main Causes of Blindness (Global):

  1. Cataract - ~47-51% (leading cause; treatable)
  2. Glaucoma - ~12% (preventable/treatable)
  3. Age-related macular degeneration - ~8-9%
  4. Corneal opacity - ~5%
  5. Diabetic retinopathy - ~4-5%
  6. Childhood blindness - ~4%
  7. Trachoma - ~3-4% (infectious; preventable)
  8. Onchocerciasis (river blindness) - ~1%
  9. Vitamin A deficiency - declining due to supplementation programs

VISION 2020 - THE RIGHT TO SIGHT

  • Launched: 1999 jointly by WHO + IAPB (International Agency for Prevention of Blindness)
  • Goal: Eliminate avoidable blindness by year 2020
  • Target diseases: Cataract, trachoma, onchocerciasis, childhood blindness, refractive errors, low vision
  • Later additions: Glaucoma, diabetic retinopathy
  • Three pillars: Disease control, human resource development, infrastructure/technology

TRACHOMA

  • Cause: Chlamydia trachomatis (serovars A, B, C) - obligate intracellular organism
  • Most common infectious cause of blindness globally
  • Transmission: Direct contact (eye-to-eye), flies, fomites
  • Reservoir: Children (active infection); adults suffer from scarring complications

WHO/FWHO Grading (MacCallan Classification):

StageFeatures
TF (Follicular)≥5 follicles ≥0.5 mm in upper tarsal conjunctiva
TI (Intense)Inflammatory thickening covering >50% of tarsal vessels
TS (Scarring)White fibrous scarring in tarsal conjunctiva
TT (Trichiasis)One or more trichiatic lashes touching the globe
CO (Corneal opacity)Opacity over pupil causing visual loss

SAFE Strategy (WHO):

  • S - Surgery (trichiasis correction - bilamellar tarsal rotation)
  • A - Antibiotics (azithromycin single dose 20 mg/kg OR tetracycline ointment 6 weeks)
  • F - Facial cleanliness
  • E - Environmental improvement (sanitation, water)

VITAMIN A DEFICIENCY (VAD)

  • Leading cause of preventable blindness in children
  • Sequence: Night blindness → Xerophthalmia → Corneal ulcer → Keratomalacia → blindness/death

Xerophthalmia Classification (WHO):

GradeFeatures
XNNight blindness
X1AConjunctival xerosis
X1BBitot's spots (triangular, foamy, whitish spot on bulbar conjunctiva temporally)
X2Corneal xerosis
X3ACorneal ulceration < 1/3 corneal area
X3BCorneal ulceration ≥ 1/3 corneal area (keratomalacia)
XSCorneal scar
XFXerophthalmic fundus

Treatment:

  • < 6 months: 50,000 IU Vitamin A orally on Days 1, 2, and 14
  • 6-12 months: 100,000 IU same schedule
  • > 12 months: 200,000 IU same schedule
  • Treat underlying malnutrition, measles

ONCHOCERCIASIS (River Blindness)

  • Cause: Onchocerca volvulus (filarial worm); transmitted by Simulium blackflies
  • Ocular features: Punctate keratitis → sclerosing keratitis; anterior uveitis; chorioretinitis; optic atrophy
  • Treatment: Ivermectin (kills microfilariae; does not kill adult worms)
  • Control: Vector control (insecticides in rivers) + mass drug administration

DIABETIC RETINOPATHY SCREENING

  • Screen all type 2 diabetics at diagnosis; type 1 diabetics after 5 years
  • Annual dilated fundal examination
  • National Diabetic Retinopathy screening programs in many countries

REFRACTIVE ERRORS

  • Most common cause of visual impairment worldwide (easily correctable)
  • Uncorrected refractive error: Major public health problem
  • School eye health programs: Vision screening for children
  • Myopia epidemic: Major concern, especially in East Asia

CATARACT - PUBLIC HEALTH ASPECTS

  • Leading cause of blindness globally and in most developing countries including India
  • Cataract Surgical Rate (CSR): Number of cataract operations per million population per year
    • Target: >3000/million/year for reducing cataract blindness
    • India: varies by state; national average improving
  • Barriers to uptake: Cost, lack of awareness, no perceived need, transport, fear of surgery, poor quality outcomes

NATIONAL PROGRAMME FOR CONTROL OF BLINDNESS (NPCB) - INDIA

  • Launched: 1976 (7th Five-Year Plan)
  • Later renamed: National Programme for Control of Blindness and Visual Impairment (NPCBVI)
  • Target: Reduce prevalence of blindness from 1.4% to 0.3%
  • Activities:
    • Cataract surgery (free of cost at government centers)
    • School eye health screening
    • Corrective glasses for school children
    • Vitamin A supplementation
    • Trachoma control
    • Diabetic retinopathy management
    • Low vision services

SCHOOL EYE HEALTH PROGRAM

  • Vision screening for myopia (most common refractive error in children)
  • Use of Snellen chart / "E" chart for illiterates
  • Referral for glasses or further evaluation
  • Screening tests: Visual acuity 6/6, cover test, color vision (Ishihara)

NATIONAL BLINDNESS SURVEY - INDIA

  • Rapid Assessment of Avoidable Blindness (RAAB) surveys
  • Prevalence of blindness in India: ~1.1-1.4%
  • Leading causes in India: Cataract (~66%), refractive errors, glaucoma, corneal blindness

QUICK REVISION CHEAT SHEET

Anti-Glaucoma Drug Mnemonics:

  • First line: Prostaglandin (once at night) → Beta-blocker → Add CAI → Add Alpha-2 agonist → Add Pilocarpine
  • Acute angle-closure: Pilocarpine 2% + Acetazolamide IV + Timolol + IV/Oral Mannitol → Definitive: Laser PI
  • Never use 2 PGAs together (paradoxical IOP rise)
  • Beta-blocker contraindicated in: Asthma, heart block, bradycardia
  • Brimonidine contraindicated in: Infants/children (CNS apnea)
  • CAI (systemic) side effect: "Pins and needles" (paraesthesia) - most common

HFA Key Numbers:

  • MD < -6 dB = Early glaucoma
  • MD -6 to -12 dB = Moderate glaucoma
  • MD > -12 dB = Advanced glaucoma
  • Fixation loss < 20% = Reliable
  • False positive < 15% = Reliable

Instruments 5-Second ID:

  • Chalazion clamp = Ring + plate → chalazion surgery
  • Evisceration scoop = Blunt spoon → scoops intraocular contents
  • Corneoscleral scissors = Spring scissors → extends corneoscleral incision
  • Two-way cannula = Double lumen → irrigation + aspiration in cataract surgery
  • Lacrimal cannula = Curved needle-sized → NLD syringing

Community Ophthalmology Numbers:

  • Blindness: < 3/60 BCVA (WHO)
  • 80% blindness avoidable
  • SAFE = trachoma strategy
  • First cause blindness globally: Cataract (47%)
  • VISION 2020: WHO + IAPB; 1999; eliminate avoidable blindness

Sources: Kanski's Clinical Ophthalmology: A Systematic Approach, 10th Ed. | Bradley and Daroff's Neurology in Clinical Practice | Wills Eye Manual | AAO EyeWiki | WHO VISION 2020 Documentation
---That's your complete ophthalmology practical exam review. Here's a summary of what's covered:

What's Included (6 Major Sections):

1. Anti-Glaucoma Drugs (Full Pharmacology)
  • 7 drug classes: Prostaglandins, Beta-blockers, Alpha-2 agonists, CAIs (topical + systemic), Miotics, Osmotics, ROCK inhibitors
  • Each drug: Class, MOA, specific agents + doses, indications, contraindications, side effects
  • Combination drugs table (Cosopt, Combigan, Simbrinza, etc.)
2. Ophthalmic Instruments (35+ instruments)
  • Chalazion clamp, Evisceration scoop (Mules), Corneoscleral scissors, Two-way irrigation-aspiration cannula, Lacrimal cannula, Chalazion scoop, Wire vectis, Cystotome, Bowman's probe, Rougine, and many more
  • Each: appearance, use, key distinguishing feature
3. Perimetry & HFA
  • Goldmann kinetic perimetry (principles, isopters, stimuli naming)
  • HFA - testing programs (24-2, 30-2, 10-2), SITA algorithms
  • Printout interpretation: MD, PSD, GHT, VFI, total/pattern deviation maps, reliability indices
  • Glaucomatous field defect patterns
4. Broader Ophthalmic Medications
  • Antibiotics, antivirals, antifungals, steroids, NSAIDs, mydriatics/cycloplegics, anti-VEGF agents, lubricants
5. Systemic Ophthalmology
  • Diabetic retinopathy (NPDR/PDR grading), hypertensive retinopathy (KWB grades), thyroid eye disease, RA, SLE, sarcoidosis, HIV, TB, MS
  • Drug-induced ocular toxicity table
6. Community Ophthalmology
  • WHO blindness definitions, global burden, VISION 2020, trachoma (SAFE strategy), Vitamin A deficiency/xerophthalmia grading, onchocerciasis, NPCB India
Best of luck at your exam tomorrow!

I have ophthalmology practical exam tomorrow. I need a perfect examination case presentation of cataract surgery patient, pseudophakia, and aphakia, mature senile cataract.

Reading File
Now let me run parallel searches for all the relevant content from the ophthalmology textbooks.
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Excellent! Found the exact sections. Let me read all the key cataract content from Kanski's now.
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Searching the Web

ophthalmology practical exam case presentation pseudophakia aphakia signs slit lamp examination findings IOL inspection

Reading File
Searching the Web

aphakia signs symptoms examination hypermetropia iridodonesis absent red reflex Purkinje images practical ophthalmology

I now have all the content I need from Kanski's Ophthalmology and supplementary sources. Let me now write the complete, structured exam case presentations.Here is your complete, exam-ready case presentation guide for all four conditions.

OPHTHALMOLOGY PRACTICAL EXAM

Complete Case Presentations: Cataract | Mature Senile Cataract | Pseudophakia | Aphakia


HOW TO APPROACH ANY CASE AT THE STATION

When you sit in front of the patient, always present in this fixed order:
"On examination of this patient..."
  1. History (brief, relevant) - chief complaint, duration, relevant history
  2. Visual Acuity - distance, near, with and without correction
  3. Torch/Penlight examination - external eye, cornea, pupil, iris, red reflex
  4. Slit Lamp Examination (anterior segment - systematic)
  5. Posterior Segment - fundus, if applicable
  6. Special Tests / Investigations
  7. Diagnosis
  8. Management

CASE 1: MATURE SENILE CATARACT


PRESENTING HISTORY (to tell the examiner)

"This is a [60-70 year old] patient who presents with a history of:
  • Gradual, painless diminution of vision in [right/left/both eyes] for [duration]
  • Patient was initially able to see but vision has been progressively worsening
  • Patient complains of:
    • Difficulty in daily activities (reading, recognizing faces)
    • Glare from headlights and sunlight
    • Difficulty seeing in low-light conditions
    • Initially had frequent change of spectacle prescription
    • No pain, no redness, no discharge
  • No history of trauma, diabetes, steroids use (or if present, note it)"*

VISUAL ACUITY

Right Eye (OD)Left Eye (OS)
Distance VAPL/PR positive (or HM, CF)Depends on the fellow eye
Near VAN36 or worse
With correctionNo improvement (mature - no fundal view possible)
PL/PRMust be positive to proceed with surgery
Key for examiner: "The visual acuity is markedly reduced to perception of light with accurate projection of rays in all four quadrants, confirming the retina is functioning - this is essential before planning surgery."
Inaccurate projection of rays = contraindication to surgery (suggests posterior segment pathology)

TORCH/PENLIGHT EXAMINATION

Stand in front of the patient, hold the torch to the side:
"On torch examination:"
  • Cornea: Clear, transparent - no vascularization, no edema
  • Anterior chamber: Deep (in most cases), no cells or flare visible
  • Pupil: Round, regular, reacting to light (direct and consensual - check!)
  • RAPD: Absent (if present, suggests posterior segment disease)
  • Iris: Normal architecture; no neovascularization
  • Lens: "The lens appears completely white/opaque on torch examination"
    • Leukocoria visible - white pupil reflex
    • No fundal glow (absent red reflex) - because the mature cataract completely blocks the red reflex
KEY CLINICAL FINDING to say loudly: "There is absent red reflex in this eye, and the pupillary area appears white - consistent with a mature cataract."

SLIT LAMP EXAMINATION (Anterior Segment)

Go through each structure systematically:
Eyelids & Lashes: Normal; no entropion, ectropion, or trichiasis
Conjunctiva: White and quiet; no injection, no discharge
Cornea:
  • Clear, transparent
  • No Descemet's folds, no bullae
  • No corneal guttae
  • Normal thickness (confirm with Van Herick: anterior chamber angle appears open)
Anterior Chamber:
  • Deep and quiet
  • No cells, no flare (grade 0)
  • In phacomorphic glaucoma: AC would be shallow due to swollen lens
Iris:
  • Normal architecture, regular pupil margin
  • No rubeosis (neovascularization of iris)
  • No posterior synechiae
Lens (KEY FINDING):
"On slit lamp examination with a narrow slit beam directed at the lens, the entire lens appears uniformly white and opaque, consistent with a MATURE SENILE CATARACT."
  • Entire lens is opacified - no clear zones visible
  • No shadows on transillumination (compare with immature cataract where you get a shadow of the iris on the opaque lens)
  • Shadow test (Oblique illumination test):
    • Shine torch obliquely from the temporal side
    • Immature cataract → crescent-shaped iris shadow visible on the lens
    • Mature cataractNO shadow (lens uniformly opaque; shadow absent)
  • Lens surface may appear somewhat wrinkled in hypermature cataract

SPECIAL TESTS

1. Shadow Test (Oblique Illumination):
  • Shine penlight from the side at 45°
  • Mature cataract → No shadow (the iris shadow does not fall on the lens because the lens is completely white - the shadow cannot be seen)
  • Immature: shadow present (clear cortex remains)
2. Red Reflex:
  • Using direct ophthalmoscope at arm's length
  • Mature cataract → Absent red reflex (the opaque lens blocks fundal reflection)
3. Projection of Rays:
  • Test in 4 quadrants (UP, DOWN, TEMPORAL, NASAL)
  • Ask patient: "From which direction is light coming?"
  • Must be positive in all 4 quadrants before surgery
  • Absent projection → retinal dysfunction → modify surgical planning / prognosis
4. Slit Lamp Examination of posterior capsule: Not possible through a mature cataract
5. B-Scan Ultrasonography:
  • Performed when fundus cannot be visualized
  • Checks: posterior vitreous detachment, retinal detachment, vitreous opacities, posterior staphyloma, intraocular foreign body
  • Normal B-scan = proceed with surgery
6. Keratometry + A-scan Biometry:
  • For IOL power calculation
  • Using SRK-T formula (most common), Holladay, Haigis formula
  • Target: emmetropia or slight myopia

DIAGNOSIS

"Based on the clinical findings of:
  • Gradual painless diminution of vision
  • Absent red reflex
  • Completely opaque, white lens on slit lamp examination
  • Absent shadow on oblique illumination
  • Positive projection of rays in all four quadrants
I diagnose this patient with a MATURE SENILE CATARACT of the [right/left] eye."

DIFFERENTIAL DIAGNOSIS

ConditionHow to differentiate
Hypermature (Morgagnian) cataractWrinkled anterior capsule; nucleus sunk inferiorly; lens may be smaller
Anterior uveitis with fibrinAC cells and flare present; keratic precipitates
Leucocoria in a childAge of patient, consider retinoblastoma, PHPV
Corneal opacityOpacity at cornea level, not in pupil

MORPHOLOGICAL STAGES OF SENILE CATARACT (MUST KNOW):

StageDescriptionShadow TestRed Reflex
ImmaturePartial opacification; some clear cortex remainsShadow present (positive)Present (may be reduced)
MatureComplete opacification; uniformly white lensShadow absent (negative)Absent
HypermatureShrunken, wrinkled capsule; cortex liquefied; leaks proteinMay be variableAbsent
MorgagnianHypermature with liquefied cortex + nucleus sunk to bottomNucleus visible inferiorlyAbsent

TYPES OF SENILE CATARACT:

TypeSlit Lamp FindingSpecial Feature
Posterior subcapsular (PSC)Granular opacity just anterior to posterior capsuleWorst visual effect; glare in bright light; myosis worsens vision
Nuclear sclerosisYellowish-brown nucleus; hard, denseMyopic shift ("second sight"); best detected with oblique beam
CorticalSpoke-like/cuneiform wedge opacities from peripheryStarts inferonasally; glare
MixedCombination of aboveMost common in elderly

MANAGEMENT

Preoperative workup:
  • Visual acuity, PL/PR, color perception
  • Keratometry + biometry (IOL power calculation - SRK-T formula)
  • B-scan (if fundus not visible)
  • Corneal endothelial cell count (specular microscopy)
  • Blood sugar, BP, CBC (if GA needed)
  • Dilated fundus examination of fellow eye
Surgical Options:
ProcedureDescriptionWhen used
PhacoemulsificationUltrasound probe emulsifies nucleus; small incision (~2.75 mm)Preferred in most cases; any grade except very hard nuclei
ECCE (Extracapsular Cataract Extraction)Nucleus expressed intact; larger incision (~10-12 mm); IOL in capsular bagHard dense cataracts (mature/hypermature); low endothelial count
SICS (Small Incision Cataract Surgery/MSICS)Manual ECCE with self-sealing incision (~5-7 mm); suturelessHigh-volume programs; mature cataracts in developing world
ICCE (Intracapsular Cataract Extraction)Entire lens including capsule removedHistorical; rarely done now - if capsule is disrupted/zonular weakness; Marfan's
IOL Implantation: PMMA/foldable acrylic IOL in the capsular bag
Postoperative care:
  • Topical antibiotic + steroid combination (e.g., moxifloxacin + dexamethasone TDS for 4 weeks)
  • NSAID drops (prevent CME)
  • Review at 1 day, 1 week, 4 weeks
  • Refraction and glasses at 6-8 weeks

CASE 2: PSEUDOPHAKIA (Patient who had cataract surgery with IOL implant)


DEFINITION

Pseudophakia = "pseudo" (false) + "phakia" (lens) → an eye containing an artificial intraocular lens (IOL) after removal of the natural crystalline lens.

HISTORY

"This patient presents for follow-up after cataract surgery [X weeks/months ago]. The patient underwent [phacoemulsification / ECCE] with IOL implantation in the [right/left] eye.
  • Patient reports improved vision post-surgery
  • May complain of: glare, halos, dysphotopsia (especially at night)
  • OR: gradual re-blurring of vision (posterior capsule opacification)
  • No pain, no discharge"

VISUAL ACUITY

Right Eye
Unaided VA6/6 to 6/18 (typically good if uncomplicated)
With correction6/6 (distance glasses may still be needed)
Near visionN6 to N8 (reading glasses needed - monofocal IOL has no accommodation)
Key point for examiner: "The patient will require reading glasses as the IOL is monofocal and does not accommodate."

TORCH EXAMINATION

  • Cornea: Scar/wound at limbus (temporal clear corneal incision - barely visible) or superior corneal scar if ECCE
  • Anterior Chamber: Deep and quiet
  • Pupil: Round, reacting to light; may be slightly irregular if synechiae present
  • RAPD: Absent (should be)
  • Red Reflex:
    "On torch examination, a BRIGHT RED REFLEX is present, indicating a clear optical media"
    • The red reflex is markedly brighter and clearer than a normal phakic eye
    • The IOL has no accommodation, so there is no "accommodative darkening" of the reflex
  • IOL reflexes (Purkinje images):
    • 4th Purkinje image from the anterior face of the lens is absent in pseudophakia (the IOL's anterior surface gives a different reflex pattern)

SLIT LAMP EXAMINATION

Cornea:
  • Clear; may see a small, self-sealing wound scar at limbus (temporal or superior)
  • Wound is sutured (ECCE) or sutureless (phaco/SICS)
  • No corneal edema in uncomplicated cases
  • If corneal edema present: suspect bullous keratopathy (Pseudophakic Bullous Keratopathy - PBK)
Anterior Chamber:
  • Deep and quiet - usually deeper than a phakic eye (IOL is thinner than natural lens)
  • No cells or flare
  • Angle is typically open
Iris:
  • May show peripheral iridotomy (PI) if performed previously
  • Gentle tremulousness (mild iridodonesis) may be present if zonular dehiscence occurred during surgery
Lens Area - KEY EXAMINATION FINDING:
"On slit lamp examination, the lens capsule is present (as the surgery was extracapsular - ECCE or phacoemulsification). Within the capsular bag, a clear artificial intraocular lens is visible."
Describe the IOL:
  • Position: In the capsular bag (most common) or in the sulcus / anterior chamber
  • Optic: Clear, round
  • Haptics: May be visible at the edge of the pupil (curved, flexible haptics)
  • IOL markings: Some IOLs have manufacturer's markings
  • Reflections: Two bright reflections (from anterior and posterior surface of IOL) seen with slit lamp
  • IOL type:
    • Posterior chamber IOL (PCIOL) in capsular bag - standard
    • Sulcus IOL - sits in the ciliary sulcus
    • Anterior chamber IOL (ACIOL) - in anterior chamber, supported by angle (older type)
Posterior Capsule - CRITICAL EXAMINATION:
"The posterior capsule appears [clear / hazy with Elschnig's pearls / fibrotic]."
  • Clear posterior capsule = uncomplicated pseudophakia
  • Posterior Capsule Opacification (PCO) = the most common late complication of cataract surgery
    • White pearl-like opacities (Elschnig's pearls) on the posterior capsule
    • Results from proliferation of residual lens epithelial cells
    • Occurs in 10-50% of patients within 3-5 years
    • Causes: gradually worsening vision, glare
    • "The posterior capsule shows Elschnig's pearls / fibrotic changes, consistent with posterior capsule opacification (PCO)."

SPECIAL TESTS FOR PSEUDOPHAKIA

1. Red Reflex:
  • Bright and uniform in uncomplicated pseudophakia
  • Reduced or absent if PCO present
2. Retroillumination:
  • Performed with slit lamp
  • PCO: opaque areas visible on retroillumination against the red reflex
3. YAG Capsulotomy (if PCO):
  • Treatment: Nd:YAG laser posterior capsulotomy
  • Creates a central opening in the opaque posterior capsule
  • Immediate restoration of vision
  • Risk: elevated IOP, CME, IOL damage, rare retinal detachment
4. Fundus Examination:
  • Dilated fundoscopy to rule out:
    • CME (cystoid macular edema)
    • Retinal detachment (risk is higher post-cataract surgery)
    • Diabetic maculopathy (if diabetic)
5. IOL Power Verification:
  • If patient has unexpected refractive error post-surgery

DIAGNOSIS

"Based on the findings of:
  • History of cataract surgery
  • Bright red reflex on torch examination
  • Corneal wound scar at limbus
  • Deep, quiet anterior chamber
  • Clear intraocular lens visible within the capsular bag on slit lamp examination
  • [Clear / Hazy] posterior capsule
I diagnose this patient with PSEUDOPHAKIA of the [right/left] eye - [uncomplicated / with PCO]."

COMPLICATIONS OF CATARACT SURGERY (TO KNOW FOR VIVA):

Immediate/Intraoperative:
  • Posterior capsule rupture with vitreous loss
  • Expulsive choroidal hemorrhage (rare but catastrophic)
  • Dropped nucleus
Early Postoperative:
  • Corneal edema
  • Striate keratopathy
  • Anterior uveitis
  • Elevated IOP (viscoelastic retained)
  • Wound leak (Seidel test positive)
  • Hyphema
Late Postoperative:
  • PCO - most common (Nd:YAG laser capsulotomy)
  • Pseudophakic bullous keratopathy (PBK)
  • Cystoid macular edema (Irvine-Gass syndrome)
  • IOL dislocation / decentration
  • Retinal detachment (especially in high myopes)
  • Endophthalmitis (rare but vision-threatening)
  • Glaucoma (secondary)

CASE 3: APHAKIA (Lens absent - No IOL implanted)


DEFINITION

Aphakia = "a" (without) + "phakos" (lens) → absence of the crystalline lens from the eye

CAUSES OF APHAKIA

  1. Post-surgical - ICCE (old technique where entire lens + capsule was removed), or ECCE/phaco complicated by posterior capsule rupture without IOL implantation
  2. Traumatic - lens expelled through a penetrating wound
  3. Congenital - primary (lens never formed) or secondary (absorption)
  4. Spontaneous subluxation/dislocation - Marfan's, homocystinuria
In your exam, it is most likely a post-surgical aphakia (elderly patient who had ICCE done many years ago before IOL era)

HISTORY

"This elderly patient has a history of [ICCE surgery] done [X years ago] in the [right/left] eye. The patient:
  • Has markedly reduced vision without glasses
  • Wears thick aphakic spectacles / contact lenses
  • Complains of 'Jack-in-the-box phenomenon' (ring scotoma with aphakic glasses)
  • May complain of difficulty with spatial perception"

VISUAL ACUITY

Right Eye (Aphakic)
Unaided VAVery poor (e.g., 6/60 or worse) - extreme high hypermetropia (+10 to +14D)
With aphakic spectacle correction (+10 to +12D)6/6 to 6/18 (if no posterior segment pathology)
Near visionSeparate bifocal addition needed

TORCH EXAMINATION

"On torch examination:"
  • Cornea: Scar at limbus
    • If ICCE: large superior limbal scar (corneoscleral incision)
    • If ECCE without IOL: similar limbal scar
    • Sutures may still be visible (interrupted or continuous nylon sutures)
  • Anterior Chamber: Typically DEEP (without a lens, the AC is much deeper than normal)
  • Iris:
    • IRIDODONESIS - characteristic trembling/quivering of the iris on eye movement
    • Normally, the lens supports the iris; without the lens, the iris wobbles
    • Ask the patient to move their eyes quickly - observe iris trembling
    • "On asking the patient to make rapid saccadic eye movements, trembling of the iris is noted - this is called IRIDODONESIS and is a sign of aphakia."
  • Pupil: Round; may have a surgical peripheral iridectomy (PI) visible - small notch in the iris at the limbus (done in ICCE to prevent pupillary block)
  • Red Reflex:
    "On torch/direct ophthalmoscope examination, there is a BRIGHTLY ENHANCED RED REFLEX - much brighter than normal, because there is no lens to attenuate the fundal reflection."
    • The red reflex in aphakia is very bright and uniform
    • This is opposite to cataract (where red reflex is absent)

SLIT LAMP EXAMINATION

Cornea:
  • Old limbal scar (superior in ICCE)
  • May have interrupted nylon sutures if old ECCE
  • Clear cornea in center typically
  • Check for: bullous keratopathy (PBK - can occur after ICCE)
Anterior Chamber:
  • DEEP ANTERIOR CHAMBER - the AC is noticeably deeper without the lens occupying posterior chamber
  • Quiet - no cells or flare (if no inflammation)
Iris:
  • May have a peripheral iridectomy (small pie-shaped notch at superior limbus)
    • PI was routinely done with ICCE to prevent pupillary block glaucoma
  • Iridodonesis (trembling) with slit lamp visible
  • Normal vasculature, no rubeosis
Lens Area - KEY FINDING:
"On slit lamp examination with the narrow slit beam directed into the pupillary area, there is a complete absence of the crystalline lens. The posterior capsule is also absent (in ICCE, entire lens including capsule was removed). The vitreous face is visible anteriorly."
  • No lens material visible in any plane
  • No capsular bag visible
  • Vitreous can be seen bulging forward (anterior hyaloid face)
  • In ECCE without IOL: Posterior capsule remnant may still be present; it differentiates from ICCE
Vitreous:
  • Anterior hyaloid face visible through the pupil
  • Vitreous herniation into AC may occur (can cause corneal touch)

SPECIAL TESTS

1. Iridodonesis Test:
  • Ask patient to make quick horizontal eye movements
  • Positive iridodonesis = aphakia (or subluxated lens)
2. Purkinje Images:
  • Normal phakic eye: 4 Purkinje images (reflections from corneal surfaces and both lens surfaces)
  • Aphakia: Only 2 Purkinje images (from cornea only; lens images absent)
  • Pseudophakia: 3-4 images (depends on IOL type)
  • Examiner's test: shine penlight toward patient's eye and count reflections
3. Red Reflex:
  • Brighter than normal in aphakia
4. Streak Retinoscopy:
  • Reflex moves "with" the streak in high degrees (high hypermetropia +10 to +14 D)
5. Fundus Examination:
  • If media is clear, do dilated fundoscopy
  • Look for: retinal detachment (higher risk after ICCE), macular degeneration, optic nerve changes

REFRACTIVE CORRECTION IN APHAKIA

MethodAdvantagesDisadvantages
Aphakic spectacle glasses (+10 to +12D convex lens)Cheap, widely available25-30% image magnification; ring scotoma; "Jack-in-the-box" phenomenon; cosmetically thick; monocular aphakia cannot tolerate
Aphakic contact lensLess magnification (~7%); better cosmesis; better for monocular aphakiaHandling difficulty in elderly; infection risk
IOL secondary implantationBest option; least magnificationSurgery needed; if no capsule: scleral-fixated IOL / ACIOL
EpikeratoplastyRefractive surgery optionRarely used now
"Jack-in-the-box phenomenon": Objects suddenly appear as they enter through the ring scotoma of aphakic glasses - disturbing and disorienting for patients.

DIAGNOSIS

"Based on the findings of:
  • History of cataract surgery (ICCE) [X years ago]
  • Poor unaided vision correctable with +10 to +12D convex lens
  • Limbal scar with peripheral iridectomy
  • Deep anterior chamber
  • Iridodonesis
  • Brilliant, enhanced red reflex
  • Complete absence of lens and posterior capsule on slit lamp
  • Only 2 Purkinje images
I diagnose this patient with APHAKIA of the [right/left] eye, most likely post-ICCE."

QUICK COMPARISON TABLE: CATARACT vs PSEUDOPHAKIA vs APHAKIA

FeatureMature Senile Cataract (Phakic)Pseudophakia (IOL present)Aphakia (No lens, No IOL)
Vision (unaided)Very poor (PL/PR)Good (6/6 to 6/18)Very poor
Vision (corrected)No improvementGoodGood with +10 to +12D
Correction neededN/AReading glasses+10 to +12D spherical
Red reflexABSENTBRIGHT/NORMALBRILLIANT/ENHANCED
Anterior chamberNormal depthDeeper than normalVery deep
IrisNormalNormalIRIDODONESIS
Shadow testABSENT (mature)N/AN/A
Slit lamp lensUniformly white opaque lensClear IOL in capsular bagNo lens visible
Purkinje images4 present3-4 (variable)Only 2
Limbal scarAbsentSmall temporal scar (phaco)Large superior scar (ICCE)
Peripheral iridectomyAbsentMay be presentOften present (ICCE)
Posterior capsulePresentPresent (may have PCO)Absent (ICCE) / Present (ECCE)

VIVA QUESTIONS AND ANSWERS (MOST COMMONLY ASKED)


Q: What is iridodonesis? What is phacodonesis?
Iridodonesis = trembling of the iris due to loss of support (aphakia, subluxated lens). Phacodonesis = trembling of the lens due to zonular weakness (subluxation). Both seen on rapid eye movements.
Q: What is the shadow test / oblique illumination test?
Penlight shone from temporal side at 45°. Crescent-shaped shadow seen on lens in IMMATURE cataract (clear cortex between iris and opacity reflects light). MATURE cataract: no shadow - the whole lens is opaque, no clear cortex to cast a shadow from the iris.
Q: How do you differentiate mature cataract from hypermature cataract?
In hypermature cataract: the anterior capsule is wrinkled and shrunken due to leakage of water out. The lens may appear smaller. In Morgagnian cataract: cortex is completely liquefied and the brown/black nucleus sinks to the bottom - visible on slit lamp.
Q: What is "second sight of the aged"?
In nuclear sclerotic cataract, increased refractive index of the nucleus causes myopic shift, allowing elderly patients (previously hypermetropic) to read without glasses again temporarily.
Q: What is the most common complication of cataract surgery?
Posterior Capsule Opacification (PCO) - occurs in 10-50% of patients over 3-5 years. Treated with Nd:YAG laser capsulotomy.
Q: What is the difference between ECCE and ICCE?
ECCE: Only nucleus and cortex removed; posterior capsule left intact; IOL placed in capsular bag. ICCE: Entire lens including capsule removed; IOL cannot be placed in capsular bag (must use ACIOL or scleral-fixated IOL); results in aphakia if no IOL.
Q: What formula is used for IOL power calculation?
SRK-T formula (most common for eyes of normal axial length). For very short eyes (<22 mm): Hoffer Q. For very long eyes (>26 mm): Haigis, SRK-T. Biometry performed using A-scan ultrasound or optical biometry (IOLMaster).
Q: What is intraoperative floppy iris syndrome (IFIS)?
Occurs in patients on systemic alpha-1 blockers (e.g., tamsulosin for BPH). The iris is flaccid, billows under irrigation, and may prolapse through incision. The pupil also constricts intraoperatively. Must inform surgeon preoperatively.
Q: What is the IOL power calculation formula for a mature cataract patient?
A-scan biometry for axial length + Keratometry for corneal curvature. Power = A constant - (2.5 × axial length) - (0.9 × K reading). For emmetropia, target = 0 D.
Q: What is Jack-in-the-box phenomenon?
In aphakic spectacle correction: due to the strong convex lens and ring scotoma, objects suddenly "pop into" view as they enter the visual field through the ring scotoma - disorienting for the patient. Not seen with contact lenses or IOLs.
Q: What are the signs of pseudophakia on slit lamp?
Clear IOL in capsular bag, bright red reflex, deep quiet anterior chamber, small limbal scar, possibly PCO, IOL haptics visible at pupil margin.
Q: What are the Purkinje images and what happens in aphakia/pseudophakia?
Purkinje I: Corneal anterior surface (upright); Purkinje II: Corneal posterior surface (upright, dimmer); Purkinje III: Lens anterior surface (upright); Purkinje IV: Lens posterior surface (inverted, brightest, used for gonioscopy lenses). Aphakia: Only P-I and P-II (2 images). Pseudophakia: Depends on IOL (usually 3 images).

HOW TO PRESENT AT THE STATION - SCRIPT

For MATURE SENILE CATARACT:

"Sir/Ma'am, on examination of this patient: History: This [65-year-old] patient presents with gradual, painless diminution of vision in the right eye for [duration]. On visual acuity testing: vision is reduced to perception and projection of light in the right eye, with accurate projection in all four quadrants, indicating a functioning retina. On torch examination: the cornea is clear. The anterior chamber appears of normal depth. The pupil is round and reacting to light. There is a white reflex visible in the pupillary area, and the red reflex is absent. On oblique illumination (shadow test): no crescent-shaped shadow is seen on the lens - the shadow test is negative, indicating complete opacification. On slit lamp examination: the cornea and anterior chamber are clear and quiet. The lens appears uniformly white and completely opacified with no clear zones remaining. On posterior segment examination: the view of the fundus is not possible due to the dense opacity. B-scan ultrasonography is advised to rule out posterior segment pathology. My diagnosis is: MATURE SENILE CATARACT of the right eye. Management: After preoperative workup including biometry and B-scan, I would recommend [ECCE with PCIOL / Phacoemulsification with IOL implantation] under local anesthesia."

Source: Kanski's Clinical Ophthalmology: A Systematic Approach, 10th Ed. - Lens chapter (pp. 322-340)
---Your complete case presentations are ready. Here's what's covered and what to focus on tonight:

Summary of What's in This Guide

4 complete case presentations with history, VA, torch exam, slit lamp, special tests, diagnosis, and management:
  1. Mature Senile Cataract - the full workup including shadow test, absent red reflex, B-scan, IOL calculation, surgical options (phaco vs ECCE vs SICS)
  2. Pseudophakia - signs of IOL in situ, posterior capsule assessment, PCO, YAG capsulotomy, complications
  3. Aphakia - iridodonesis, brilliant red reflex, deep AC, 2 Purkinje images, limbal scar + PI, aphakic correction (+10-12D), Jack-in-the-box phenomenon
  4. Cataract types - PSC vs Nuclear vs Cortical vs mature/hypermature/Morgagnian with distinguishing features

The 3 Most Exam-Critical Points to Memorize Right Now

SignMature CataractPseudophakiaAphakia
Red reflexABSENTBright/normalBRILLIANT (enhanced)
Shadow testNEGATIVE (absent)N/AN/A
IridodonesisAbsentAbsentPRESENT
Purkinje images: Phakic = 4, Aphakia = 2, Pseudophakia = 3-4
Shadow test rule: Shadow PRESENT = immature (clear cortex); Shadow ABSENT = mature (no clear cortex to reflect)
All the best for tomorrow - you've got this!
This is a shared conversation. Sign in to Orris to start your own chat.